HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Evidence that low protein C contributes to the procoagulant imbalance in cirrhosis.

AbstractBACKGROUND & AIMS:
Cirrhosis is associated with a plasmatic procoagulant imbalance, detected in vitro by thrombin generation tests performed in the presence vs. absence of such activators of protein C as thrombomodulin or Protac. This imbalance is thought to be due to decreased protein C and increased factor VIII, but this has never been directly demonstrated. To test this hypothesis we analyzed plasma from 50 patients with cirrhosis before and after in vitro addition of purified protein C meant to restore normal levels.
METHODS:
Results for two thrombin generation assays were expressed as ratios of endogenous thrombin potential (ETP) with-to-without thrombomodulin or as Protac-induced coagulation inhibition (PICI%). By definition, high ETP ratios or low PICI% reflect a resistance to the anticoagulant action of thrombomodulin or Protac, respectively, and can be taken as indexes of in vitro procoagulant imbalance.
RESULTS:
The median (range) protein C level before addition was 40% (4-101%) and increased to 156% (110-305) after addition (p<0.001). The procoagulant imbalance, which was high before protein C addition [ETP ratio=0.83 (0.44-1.00)], was reduced after addition [ETP ratio=0.60 (0.14-0.84)], p<0.001. ETP-ratios were inversely correlated with protein C activity (rho=-0.46, p<0.001). Similar results were obtained with the Protac assay.
CONCLUSIONS:
The results provide evidence that low protein C contributes to the procoagulant imbalance in plasma from patients with cirrhosis. The findings may have clinical implications for the treatment or prophylaxis of thrombosis in these patients.
AuthorsArmando Tripodi, Massimo Primignani, Laura Lemma, Veena Chantarangkul, Pier Mannuccio Mannucci
JournalJournal of hepatology (J Hepatol) Vol. 59 Issue 2 Pg. 265-70 (Aug 2013) ISSN: 1600-0641 [Electronic] Netherlands
PMID23583273 (Publication Type: Journal Article)
CopyrightCopyright © 2013 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
Chemical References
  • Blood Coagulation Factors
  • Intercellular Signaling Peptides and Proteins
  • Peptides
  • Protein C
  • Thrombomodulin
  • snake venom protein C activator
  • Thrombin
Topics
  • Aged
  • Aged, 80 and over
  • Blood Coagulation (drug effects, physiology)
  • Blood Coagulation Factors (metabolism)
  • Blood Coagulation Tests
  • Female
  • Humans
  • Intercellular Signaling Peptides and Proteins
  • Liver Cirrhosis (blood, complications)
  • Male
  • Middle Aged
  • Peptides (pharmacology)
  • Protein C (metabolism, therapeutic use)
  • Protein C Deficiency (blood, complications, drug therapy)
  • Risk Factors
  • Thrombin (biosynthesis)
  • Thrombomodulin (blood)
  • Venous Thromboembolism (blood, etiology, prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: